215 related articles for article (PubMed ID: 20226061)
1. LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications.
Ghosh S; Ghosh A; Maiti GP; Mukherjee N; Dutta S; Roy A; Roychoudhury S; Panda CK
Mol Cancer; 2010 Mar; 9():58. PubMed ID: 20226061
[TBL] [Abstract][Full Text] [Related]
2. Differential transmission of the molecular signature of RBSP3, LIMD1 and CDC25A in basal/ parabasal versus spinous of normal epithelium during head and neck tumorigenesis: A mechanistic study.
Sarkar S; Alam N; Mandal SS; Chatterjee K; Ghosh S; Roychoudhury S; Panda CK
PLoS One; 2018; 13(4):e0195937. PubMed ID: 29672635
[TBL] [Abstract][Full Text] [Related]
3. Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: Correlation with progression and prognosis.
Ghosh S; Ghosh A; Maiti GP; Alam N; Roy A; Roy B; Roychoudhury S; Panda CK
Int J Cancer; 2008 Dec; 123(11):2594-604. PubMed ID: 18792900
[TBL] [Abstract][Full Text] [Related]
4. Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance.
Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Zabarovsky ER; Roy A; Roychoudhury S; Panda CK
Cancer Sci; 2010 Jun; 101(6):1511-20. PubMed ID: 20412120
[TBL] [Abstract][Full Text] [Related]
5. Differential alterations of the genes in the CDKN2A-CCND1-CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients.
Tripathi Bhar A; Banerjee S; Chunder N; Roy A; Sengupta A; Roy B; Roychowdhury S; Panda CK
J Cancer Res Clin Oncol; 2003 Nov; 129(11):642-50. PubMed ID: 14586645
[TBL] [Abstract][Full Text] [Related]
6. SNP rs1049430 in the 3'-UTR of SH3GL2 regulates its expression: Clinical and prognostic implications in head and neck squamous cell carcinoma.
Maiti GP; Ghosh A; Mondal P; Baral A; Datta S; Samadder S; Nayak SP; Chakrabarti J; Biswas J; Sikdar N; Chowdhury S; Roy B; Roychowdhury S; Panda CK
Biochim Biophys Acta; 2015 May; 1852(5):1059-67. PubMed ID: 25728707
[TBL] [Abstract][Full Text] [Related]
7. Frequent inactivation of SLIT2 and ROBO1 signaling in head and neck lesions: clinical and prognostic implications.
Maiti GP; Ghosh A; Mondal P; Ghosh S; Chakraborty J; Roy A; Roychowdhury S; Panda CK
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Feb; 119(2):202-12. PubMed ID: 25465073
[TBL] [Abstract][Full Text] [Related]
8. Preferential allelic deletion of RBSP3, LIMD1 and CDC25A in head and neck squamous cell carcinoma: Implication in cancer screening and early detection.
Sarkar S; Panda CK
Cancer Biol Ther; 2018 Jul; 19(7):631-635. PubMed ID: 29624473
[TBL] [Abstract][Full Text] [Related]
9. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma.
El-Naggar AK; Lai S; Clayman G; Lee JK; Luna MA; Goepfert H; Batsakis JG
Am J Pathol; 1997 Dec; 151(6):1767-74. PubMed ID: 9403727
[TBL] [Abstract][Full Text] [Related]
10. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genes.
Maiti GP; Mondal P; Mukherjee N; Ghosh A; Ghosh S; Dey S; Chakrabarty J; Roy A; Biswas J; Roychoudhury S; Panda CK
PLoS One; 2013; 8(5):e63440. PubMed ID: 23675485
[TBL] [Abstract][Full Text] [Related]
12. Alterations of ROBO1/DUTT1 and ROBO2 loci in early dysplastic lesions of head and neck: clinical and prognostic implications.
Ghosh S; Ghosh A; Maiti GP; Alam N; Roy A; Roychoudhury S; Panda CK
Hum Genet; 2009 Mar; 125(2):189-98. PubMed ID: 19104841
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of LIMD1-VHL-HIF-1α-VEGF pathway is associated with different stages of cervical cancer.
Chakraborty C; Mitra S; Roychowdhury A; Samadder S; Dutta S; Roy A; Das P; Mandal RK; Sharp TV; Roychoudhury S; Panda CK
Biochem J; 2018 May; 475(10):1793-1806. PubMed ID: 29654110
[TBL] [Abstract][Full Text] [Related]
14. Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour.
Sabbir MG; Roy A; Mandal S; Dam A; Roychoudhury S; Panda CK
Int J Exp Pathol; 2006 Apr; 87(2):151-61. PubMed ID: 16623759
[TBL] [Abstract][Full Text] [Related]
15. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
[TBL] [Abstract][Full Text] [Related]
16. High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.
Basu M; Chatterjee A; Chakraborty B; Chatterjee E; Ghosh S; Samadder S; Pal DK; Roy A; Chakrabarti J; Ghosh A; Panda CK
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2309-2322. PubMed ID: 34080067
[TBL] [Abstract][Full Text] [Related]
17. Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck.
Ghosh A; Ghosh S; Maiti GP; Mukherjee S; Mukherjee N; Chakraborty J; Roy A; Roychoudhury S; Panda CK
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S528-38. PubMed ID: 21861228
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a.
Waber P; Dlugosz S; Cheng QC; Truelson J; Nisen PD
Oncogene; 1997 Oct; 15(14):1699-704. PubMed ID: 9349503
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
Gorgoulis VG; Zacharatos P; Kotsinas A; Liloglou T; Kyroudi A; Veslemes M; Rassidakis A; Halazonetis TD; Field JK; Kittas C
Am J Pathol; 1998 Dec; 153(6):1749-65. PubMed ID: 9846966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
